Overall, current study provides more mechanistic insights into the linkage of adipose tissue, adipokines and inflammation to metabolic syndrome and also more evidences for detection of decreased HMW-adiponectin and leptin resistance in clinical settings to prevent metabolic disorders and future diabetic and cardiovascular outcomes. The gene discussed is ADIPOQ; the disease is metabolic syndrome.